# GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

> **NCT02302976** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 13 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** cocaine hydrochloride
- **DRUG:** exenatide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02302976
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302976, "GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02302976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*